Opinion
Civil Action 20-4660-KSM
03-25-2022
HALMAN ALDUBI PROVIDENT AND PENSION FUNDS LTD., Plaintiff, v. TEVA PHARMACEUTICALS INDUSTRIES LIMITED, et al., Defendants.
ORDER
KAREN SPENCER MARSTON, J.
AND NOW, this 25th day of March, 2022, upon consideration of Defendants' Motion to Dismiss the Corrected Amended Complaint (Doc. No. 66), Lead Plaintiff's Memorandum of Law in Opposition to Defendants' Motion to Dismiss the Corrected Amended Complaint (Doc. No. 68), Defendants' Reply Memorandum in Further Support of Defendants' Motion to Dismiss the Corrected Amended Complaint (Doc. No. 70), and following oral argument on March 22, 2022 (Doc. No. 71), it is ORDERED that Defendants' Motion to Dismiss (Doc. No. 66) is GRANTED IN PART and DENIED IN PART. It is further ORDERED as follows:
1. Defendants' Motion to Dismiss is GRANTED as to Defendant Eli Kalif.
2. Defendants' Motion to Dismiss is DENIED as to Defendant Teva Pharmaceutical Industries Limited and as to Individual Defendants Erez Vigodman, Eyal Desheh, Robert Koremans, Michael Derkacz, Kare Schultz, Michael McClellan, and Brendan O'Grady.
IT IS SO ORDERED.